Neoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
Neoadjuvant therapy with an NHA associated with longer time to biochemical recurrence, prolonged metastasis-free survival
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.